BiVictriX Therapeutics (LSE:BVX) 10-Year Share Buyback Ratio : 0.00% (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is BiVictriX Therapeutics 10-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. BiVictriX Therapeutics's current 10-Year Share Buyback Ratio was 0.00%.

LSE:BVX's 10-Year Share Buyback Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: -12.55
* Ranked among companies with meaningful 10-Year Share Buyback Ratio only.

Competitive Comparison of BiVictriX Therapeutics's 10-Year Share Buyback Ratio

For the Biotechnology subindustry, BiVictriX Therapeutics's 10-Year Share Buyback Ratio, along with its competitors' market caps and 10-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BiVictriX Therapeutics's 10-Year Share Buyback Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BiVictriX Therapeutics's 10-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where BiVictriX Therapeutics's 10-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

BiVictriX Therapeutics 10-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from ten years ago to the current year. The annualized percentage change is calculated with least-square regression based on the eleven years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

BiVictriX Therapeutics (LSE:BVX) 10-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

BiVictriX Therapeutics 10-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of BiVictriX Therapeutics's 10-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

BiVictriX Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BiVictriX Therapeutics PLC (LSE:BVX) » Definitions » 10-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

Alderley Edge, Mereside, Alderley Park, Macclesfield, GBR, SK10 4TG

Website

https://www.bivictrix.com

BiVictriX Therapeutics PLC is a drug development company. It has developed its proprietary Bi-Cygni technology which utilizes Antibody Drug Conjugates for the treatment of various cancers including Acute Myeloid Leukaemia. The Group has one reportable segment, being the development of pharmaceutical products within the United Kingdom.

BiVictriX Therapeutics Headlines

No Headlines